Preparation and crystallization of a human immunodeficiency virus p24-Fab complex

A J Prongay1, T J Smith, M G Rossmann

  • 1Department of Biological Sciences, Purdue University, West Lafayette, IN 47907.

Insights

Researchers crystallized a complex of human immunodeficiency virus capsid protein (p24) and a specific antibody fragment (Fab25.4). These crystals diffracted X-rays, aiding structural studies of HIV proteins.

Area of Science:

  • Structural Biology
  • Virology
  • Immunology

Background:

  • The human immunodeficiency virus (HIV) capsid protein p24 is a key viral component and a target for antibody-based diagnostics and therapeutics.
  • Understanding the structure of p24 and its interactions with antibodies is crucial for developing effective HIV interventions.

Purpose of the Study:

  • To obtain well-diffracting crystals of a complex formed between recombinant HIV p24 and a specific monoclonal antibody fragment (Fab25.4).
  • To characterize the crystal structure of the p24-Fab25.4 complex for further structural analysis.

Main Methods:

  • Purification of recombinant HIV p24 and monoclonal antibody Fab25.4.
  • Complex formation between p24 and Fab25.4.
  • Crystallization of the p24-Fab25.4 complex using vapor-diffusion with PEG 3350.
  • X-ray diffraction analysis of the obtained crystals.

Main Results:

  • Two distinct isoelectric forms of recombinant p24 and Fab25.4 were purified.
  • A stable complex between p24 and Fab25.4 was formed and crystallized.
  • Two crystal morphologies were obtained, with one monoclinic crystal form (space group P2(1)) diffracting X-rays to 2.7-A resolution.

Conclusions:

  • The successful crystallization and initial X-ray diffraction data of the p24-Fab25.4 complex provide a foundation for detailed structural determination.
  • This structural information can aid in understanding HIV-p24 antigenicity and antibody binding, potentially informing vaccine design or therapeutic strategies.